Inhibitory role of angiopoietin‑like 4 for cancer progression in oropharyngeal squamous cell carcinoma
Authors:
Open Access
- 20 April 2026
- journal article
- Published by Spandidos Publications in Oncology Reports
- Vol. 55 (6) , 1-12
Abstract
The mortality rate of head and neck squamous cell carcinoma (HNSCC), one of the most prevalent types of cancer, has remained unchanged despite advances in treatment strategies. Angiopoietin‑like 4 (ANGPTL4) exhibits both pro‑ and anti‑tumorigenic roles in various cancers depending on the tissue context. The present study investigated the role of ANGPTL4 expression in oropharyngeal squamous cell carcinoma (OPSCC). Data from 137 patients with OPSCC who underwent initial treatment were retrospectively analyzed. ANGPTL4 expression in tumor tissues was determined via immunohistochemistry. Survival outcomes [overall survival (OS) and disease‑free survival (DFS)] and clinicopathological correlations were evaluated. Tumor cell proliferation was assessed using an CellTiter‑Glo 2.0 luminescence‑based cell viability assay, immunofluorescence staining, and reverse transcription‑quantitative polymerase chain reaction following small interfering RNA‑mediated knockdown in a HNSCC cell line. Gene set enrichment analysis (GSEA) was performed using data from The Cancer Genome Atlas. ANGPTL4 expression (≥7.7%) in patients with OPSCC was significantly associated with improved OS and DFS. Multivariate analysis confirmed that low ANGPTL4 expression was an independent prognostic factor for OS [hazard ratio (HR)=3.676, 95% confidence interval (CI)=1.678‑8.056; P=0.001) and DFS (HR=2.959, 95% CI=1.533‑5.713; P=0.001)]. FaDu cells with ANGPTL4 knockdown demonstrated significantly increased proliferation compared with negative controls in the CellTiter‑Glo 2.0 assay (P=0.010), accompanied by a significant increase in Ki‑67 expression as revealed by immunofluorescence staining (P=0.021). The relative ANGPTL4 mRNA expression levels decreased to 38%, whereas those of MKI67 increased significantly. GSEA revealed significant enrichment of cell cycle progression signatures in cases with low ANGPTL4 expression. ANGPTL4 expression was significantly associated with a favorable prognosis in OPSCC, and its knockdown increased proliferative activity in FaDu cells. Thus, ANGPTL4 may serve as a prognostic biomarker in OPSCC. Further in vivo studies are warranted to clarify causality and assess the therapeutic potential of ANGPTL4 targeting in OPSCC.Keywords
This publication has 29 references indexed in Scilit:
- Dual blockage of P-cadherin and c-Met synergistically inhibits the growth of head and neck cancerCellular Oncology, 2025
- Placental-Cadherin, a biomarker for local immune status and poor prognosis among patients with tongue squamous cell carcinomaEuropean Archives of Oto-Rhino-Laryngology, 2021
- The downregulation of ANGPTL4 inhibits the migration and proliferation of tongue squamous cell carcinomaArchives of Oral Biology, 2016
- ANGPTL4 Correlates with NSCLC Progression and Regulates Epithelial-Mesenchymal Transition via ERK PathwayLung, 2016
- Angiopoietin-like 4 enhances metastasis and inhibits apoptosis via inducing bone morphogenetic protein 7 in colorectal cancer cellsBiochemical and Biophysical Research Communications, 2015
- NDRG1 attenuates epithelial–mesenchymal transition of nasopharyngeal cancer cells via blocking Smad2 signalingBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2015
- N-myc downstream-regulated gene 1 downregulates cell proliferation, invasiveness, and tumorigenesis in human oral squamous cell carcinoma11Equal contributions.Cancer Letters, 2014
- P-Cadherin Promotes Liver Metastasis and Is Associated with Poor Prognosis in Colon CancerThe American Journal of Pathology, 2011
- Trends in incidence and prognosis for head and neck cancer in the United States: A site‐specific analysis of the SEER databaseInternational Journal of Cancer, 2005
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001